Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,145,804
+$2,409,360 QoQ
Shares Held
244,302
+108.5% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 279 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Derivatives in AUPH
reported options exposure · as of Jun 30, 2023CallValue
$193,600
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. AUPH ranks #179 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in AUPH
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,145,804 | 244,302 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,736,444 | 117,169 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,775,980 | 738,306 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,111,331 | 100,573 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,393,382 | 164,508 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $181,503 | 22,575 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $785,040 | 87,421 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $427,522 | 58,325 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $67,206 | 11,770 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $94,122 | 18,787 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $261,573 | 29,096 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $124,988 | 16,086 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $193,600 | 20,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $161,956 | 16,731 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $578,424 | 52,776 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $486,432 | 112,600 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $86,400 | 20,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $150,400 | 20,000 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $201,000 | 20,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $247,600 | 20,000 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $8,945,726 | 722,595 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,659,200 | 160,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $8,484,420 | 383,390 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $663,900 | 30,000 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $663,900 | 30,000 | Put | Sole | 2021-11-15 | |
| 2021-03-31 | $824,651 | 63,508 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $1,298,500 | 100,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $189,567 | 13,707 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,843,734 | 668,278 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,338,228 | 143,891 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,921,472 | 408,096 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||